Statements (25)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:activeIngredient |
gptkb:dronedarone
|
| gptkbp:approvalYear |
2009
|
| gptkbp:approvedBy |
gptkb:FDA
|
| gptkbp:ATCCode |
C01BD07
|
| gptkbp:CASNumber |
141625-93-6
|
| gptkbp:chemicalFormula |
C31H44N2O5S
|
| gptkbp:contraindication |
severe heart failure
permanent atrial fibrillation |
| gptkbp:eliminationHalfLife |
13-19 hours
|
| https://www.w3.org/2000/01/rdf-schema#label |
Multaq
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
gptkb:Sanofi
|
| gptkbp:mechanismOfAction |
antiarrhythmic (Class III)
|
| gptkbp:pregnancyCategory |
gptkb:X_(US)
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
nausea
diarrhea bradycardia liver injury |
| gptkbp:tradeNameOf |
gptkb:dronedarone
|
| gptkbp:usedFor |
gptkb:atrial_fibrillation
atrial flutter |
| gptkbp:bfsParent |
gptkb:赛诺菲
|
| gptkbp:bfsLayer |
6
|